Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ME-344 |
Trade Name | |
Synonyms | |
Drug Descriptions |
ME-344 is an isoflavone derivative which interferes with mitochondrial energy production in tumor cells resulting in caspase-independent cell death (PMID: 25411085, PMID: 31597662). |
DrugClasses | |
CAS Registry Number | 1374524-68-1 |
NCIT ID | C101132 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + ME-344 | Bevacizumab ME-344 | 0 | 1 |
ME-344 | ME-344 | 0 | 0 |
ME-344 + Topotecan | ME-344 Topotecan | 0 | 1 |